News

Murrieta, CA – September 28, 2017 

Apparently, many Americans spend the holidays doing more than hanging up stockings and trimming the tree. September happens to wear the noteworthy title of “most popular birth month in the United States”. Count back nine months and … you get the point.

Murrieta, CA – September 14, 2017 

It isn’t every day that a company hits four milestones with the placement of one system. But that is exactly what happened last month at the University Health Network/Sinai Health System’s Department of Microbiology in Toronto, Ontario when COPAN installed WASPLab®, a fully automated specimen processor and work-up system for microbiology, which comprises robotic culture and incubation of specimens, digital imaging and artificial intelligence to assist interpretation and reporting of patient results.

Murrieta, CA – July 24, 2017

After a successful launch at the American Society for Microbiology (ASM) Microbe 2017, COPAN is showcasing PhenoMATRIX™ to a wider audience at the American Association for Clinical Chemistry (AACC) annual meeting at the San Diego Convention Center from August 1 through August 3.

New Orleans, CA – June 14, 2017

NEW ORLEANS — A novel home-based self-sampling vaginal swab for detection of STDs produced the same results as a swab used under the supervision of a gynecologist and was preferred by 80% of patients, according to the results of a study presented at ASM Microbe. 

Check out the article

Murrieta, CA – April 21st, 2017

When it comes to stool, sometimes less is more. A recent study published in the Journal of Clinical Microbiology titled “Evaluation of the New FecalSwab™ to Maintain Stability of Stool Samples Submitted for Molecular Tests” concluded that this is particularly true when taking advantage of the convenience and accuracy of COPAN’s latest product addition: FecalSwab™. The study, released on March 15, 2017 set out to determine the most effective, rapid and least invasive method to collect stool samples and quickly treat patients suffering from gastrointestinal diseases. 

Murrieta, CA May 5th, 2017

GI Pathogens can be difficult to detect due to the lack of sensitivity and speed experienced with traditional methods and patients having trouble providing a timely specimen. To help remedy these issues COPAN’s FecalSwab™ (FS) has been the focal point of several recent evaluations. As a kit, FecalSwab™ comes with a regular COPAN flocked swab (FLOQSwabs™) and 2 mL of Cary-Blair medium. Many clinicians have considered using the flocked swab as a rectal swab, in scenarios where timely access to a sample is crucial, and ability to collect a fresh stool is unmanageable. There is an unmet clinical need in pediatric settings when the patient shows up with acute symptoms and a sample needs to be immediately obtained for testing. In a continuation of an earlier study, Dr. Chapin and her team presented Comparison of Results Obtained with the FilmArray GI Panel Using Rectal Swabs and Cary-Blair Stool from Patients with Gastroenteritis in the Pediatric Emergency Dept., which entailed studying the use of FecalSwab™ as a rectal collection device that could be administered upon patient visit in conjunction with a widely accepted rapid detection assay, the FilmArray Gastrointestinal Panel (BioFire Diagnostics). While FecalSwab™ has had FDA clearance since Spring of 2015, the use of FS as a rectal swab collection device used in conjunction with a molecular FilmArray GI Panel has not been cleared by the FDA. 

Murrieta, CA April 28th, 2017

When you got it, flaunt it. It appears the use of FecalSwab™ is popping up everywhere.
A brandnew study presented at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria examined the use of FecalSwab™ for yet another major molecular diagnostic platform, the Seegene Allplex gastrointestinal multiplex PCR. In this study, Rebbapragada et al examined FecalSwab’s compatibility with the Seegene’s molecular chemistry, and FecalSwab’s convenience and utility when used with an automated pipetting platform employed within the assay. The study showed FecalSwab’s improved limit of detection when compared to traditional enteric transport media. 

ECCMID
22-25 April 2017
Vienna, Austria

 VISIT COPAN AT ECCMID 2017, BOOTH #14

Copan Italia SPA
Seleziona 1 candidato che sarà assegnatario di borsa di studio aziendale per il profilo di Tecnico specializzato sul tema dell’adaptive manufacturing applicato alle apparecchiature per esami di laboratorio.

Page 1 of 2